Inhibition of gallbladder cancer xenograft growth on nude mice upon treatment with SST (1 mg/kg), DOX (2 mg/kg), or a combination of both (2 mg/kg DOX with either 1 mg/kg or 2 mg/kg SST)

<p><b>Copyright information:</b></p><p>Taken from "The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma"</p><p>http://www.biomedcentral.com/1471-2407/7/125</p><p>BMC Cancer 2007;7():125-125.</p><p>Published online 8 Jul 2007</p><p>PMCID:PMC1931603.</p><p></p> Means that are significantly different from the control group are indicated with an asterisk (< 0.05)